Arda Ural of Ernst and Young says there are favorable conditions going on in the medtech industry that could help lead to more acquisitions in the space.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,